Clinical Trials Logo

Filter by:
NCT ID: NCT05123768 Completed - Cerebral Palsy Clinical Trials

Genetic Etiology in Patients With Cerebral Palsy

GenCP
Start date: April 1, 2021
Phase:
Study type: Observational [Patient Registry]

Cerebral palsy (CP) is a permanent disorder of movement or posture due to non-progressive impairments of the developing brain. Current estimates indicate that as many as 30% of CP cases may be genetic in nature. In our study, the investigators will re-examine the data of children with CP, who are registered in the Slovenian National Registry of Cerebral Palsy. All children will be invited to the University Children's Hospital, University Medical Centre Ljubljana, where they will be re-examined by a neurologist. Blood for genetic testing will be taken. In the case of confirmed genetic ethiology of CP, the search for specific therapy will be possible.

NCT ID: NCT05100680 Completed - Nail Damage Clinical Trials

Study of the Effect of 12-week Dietary Supplementation With a Multicomponent Nutritional Supplement on Nails and Skin

VISTMULTIK
Start date: November 25, 2019
Phase: N/A
Study type: Interventional

A double-blind, randomized, placebo-controlled efficacy study in one period will include 34 participants divided into two groups. One group will receive a test product (n = 22; test group; multicomponent dietary supplement including MSM and several vitamins and minerals); the other group received placebo capsules (n = 12; placebo group; only modified starch). Volunteers will take two capsules / day orally continuously daily for 12 weeks to assess the effect of these substances on nail growth and condition and skin.

NCT ID: NCT05095805 Completed - Amputation Clinical Trials

Weight-bearing Exercise for Trans-tibial Amputees

Prototest
Start date: October 14, 2021
Phase: N/A
Study type: Interventional

A simple weight-bearing exercise has been designed using off-the-shelves devices (Nintendo Wii Balance Board) and centre of pressure (COP) analysis software (Python) for trans-tibial amputees receiving their first prosthesis. A pilot randomised control study will be conducted to check the progress with weight-bearing training using COP-based objective measures. Additionally, gait and functional task performance will be assessed by means of clinical test. Participants will be divided into 2 groups: test group (performing additional weight-bearing exercises) and control group (receiving only conventional training for fitting of initial prosthesis).

NCT ID: NCT05094713 Completed - Ischemia Clinical Trials

Effects of Muscle Flossing on Quadriceps Muscle Potentiation

MF_TMG_CMJ
Start date: July 20, 2021
Phase: N/A
Study type: Interventional

Tissue flossing involves wrapping a thick rubber band around a joint or muscle, which can partially occlude blood flow. In practice, it is often used while concomitantly performing a range of motion exercises (ROM) for 1 to 3 minutes in duration. The mechanisms involved in tissue flossing with a floss band may be similar to those involved in ischemic preconditioning. Previous results would support the use of tissue flossing on ROM, while there are no clear conclusions on post-activation effects on sports-related performance and muscle contractile properties. This may be attributed to the different methodologies used in the studies. Therefore, the time course associated with tissue flossing benefits remains to be investigated.

NCT ID: NCT05077033 Completed - Clinical trials for Basal Cell Carcinoma

Intratumoral phIL12 GET

SmartGeneH&N
Start date: September 28, 2021
Phase: Phase 1
Study type: Interventional

Electroporation provides non-viral gene delivery method for plasmid DNA. Its clinical application was already proven in preclinical and in clinical trial in treatment of melanoma skin metastases with plasmid coding IL-12, in USA. Intratumoral gene transfer of plasmid coding for IL-12 has proven safe end effective, having good local tumour control and some evidence indicates on abscopal effect. The EU directives recommend the use of plasmids without the gene for antibiotic resistance. For this purpose we constructed plasmid coding for IL-12 in accordance with the EU regulatory requirements. In the proposed study we intend to study the safety and tolerability of the constructed plasmid, phIL12, in treatment of basal cell carcinomas in patients with operable tumors in head and neck region. The study is designed as exploratory, dose escalating with the aim to determine the dose of plasmid that produces IL-12 expression in the tumours with best biological activity, infiltration of the immune cells and no toxicity.

NCT ID: NCT05068037 Completed - Clinical trials for Postoperative Nausea and Vomiting

Influence of Hypnoacupuncture on Early Perioperative Recovery

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

Perioperative stress is associated with various influences before and after surgery. Instead of benzodiazepines, patients can be calmed by non-pharmacological methods. One of these is perioperative medical hypnosis, which has also other beneficial effects such as lower opioid consumption, better wound healing, shorter hospital stays. Acupuncture is used for analgesia. Is is effective for preventing and treating nausea and vomiting. Hypothesis of the study is that perioperative acupuncture reduces the consumption of analgesics and anaesthetics during surgery. The investigators will also study the impact of acupuncture on postoperative nausea and vomiting and analgesic consumption in the postoperative recovery unit and the occurrence of postoperative delirium.

NCT ID: NCT05054959 Recruiting - Clinical trials for Locally Advanced Rectal Cancer

Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence

ICONA
Start date: June 24, 2021
Phase: Phase 2
Study type: Interventional

The purpose of the study is to identify the most promising sequence of modalities in total neoadjuvant treatment of localy advanced rectal cancer with high risk of recurrence

NCT ID: NCT05043103 Recruiting - Clinical trials for Advanced Parkinson Disease

Long-Term Observational Study on Effectiveness and Safety of Lecigon in Patients With Advanced Parkinson's Disease

ELEGANCE
Start date: July 6, 2021
Phase:
Study type: Observational

This observational study is designed to collect data on the use of the drug Lecigon® in daily clinical practice. The study is organised and funded by a pharmaceutical company called Britannia Pharmaceuticals Ltd (Britannia). Lecigon® is prescribed by physicians in advanced Parkinson's disease when patients suffer from uncontrollable fluctuations in mobility, so-called motor fluctuations, which cannot be adjusted well with oral treatment, i.e. medication for swallowing. In this study, data on the effect and possible side effects from everyday treatment with Lecigon® will be collected and scientifically evaluated. The study is intended to supplement the results of previous clinical studies with clinical data in routine medical care, collected from approximately 300 patients.

NCT ID: NCT05030428 Active, not recruiting - Clinical trials for Atherosclerotic Cardiovascular Disease

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

VICTORION-2P
Start date: November 23, 2021
Phase: Phase 3
Study type: Interventional

Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants with established cardiovascular disease (CVD).

NCT ID: NCT05018767 Recruiting - Frailty Clinical Trials

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty

Start date: January 22, 2022
Phase: Phase 1
Study type: Interventional

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Aging Frailty